Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fatal intracranial haemorrhage associated with the administration of low-molecular-weight-heparin in a child.

× No keyword cloud information.

8 in total

1. Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors: Gordon Guyatt; Holger J Schünemann; Deborah Cook; Roman Jaeschke; Stephen Pauker
Journal: Chest Date: 2004-09 Impact factor: 9.410

2. Life threatening haemorrhagic events associated with the administration of low-molecular-weight-heparin.

Authors: Dara Kavanagh; Arnold D K Hill; Sean Martin; Colm Power; Enda W McDermott; Niall O'Higgins; Karen Murphy
Journal: Thromb Haemost Date: 2004-04 Impact factor: 5.249

3. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study.

Authors: P Massicotte; M Adams; V Marzinotto; L A Brooker; M Andrew
Journal: J Pediatr Date: 1996-03 Impact factor: 4.406

4. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial.

Authors: Patricia Massicotte; Jim A Julian; Michael Gent; Karen Shields; Velma Marzinotto; Barbara Szechtman; Maureen Andrew
Journal: Thromb Res Date: 2003-01-25 Impact factor: 3.944

Review 8. Cardioembolic stroke: an update.

Authors: José M Ferro
Journal: Lancet Neurol Date: 2003-03 Impact factor: 44.182

8 in total

1 in total

Review 1. Spontaneous posterior fossa hemorrhage associated with low-molecular weight heparin in an adolescent recently diagnosed with posterior reversible encephalopathy syndrome: case report and review of the literature.

Authors: Theofilos G Machinis; Kostas N Fountas; Vassilios G Dimopoulos; E Christopher Troup
Journal: Childs Nerv Syst Date: 2006-09-08 Impact factor: 1.475

1 in total

Fatal intracranial haemorrhage associated with the administration of low-molecular-weight-heparin in a child.

1. Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

2. Life threatening haemorrhagic events associated with the administration of low-molecular-weight-heparin.

3. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study.

4. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial.

5. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy.

6. The use of low molecular weight heparin in pediatric patients: a prospective cohort study.

Review 7. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Review 8. Cardioembolic stroke: an update.

Review 1. Spontaneous posterior fossa hemorrhage associated with low-molecular weight heparin in an adolescent recently diagnosed with posterior reversible encephalopathy syndrome: case report and review of the literature.